FEATURES OF BONE METABOLISM AND THE ROLE OF MRI IN THE DIAGNOSIS OF CHARCOT'S FOOT IN PATIENTS WITH TYPE 2 DIABETES MELLITUS

被引:0
|
作者
Kamalov, T. T. [1 ]
Tojiboev, S. S. [2 ]
Shokirov, Kh. Sh. [2 ]
Talanova, V. A. [2 ]
机构
[1] Acad EKh Turakulov, Minist Hlth Republ Uzbekistan, Republican Specialized Sci & Pract Med Ctr Endocr, Dept Diabet Foot, Tashkent, Uzbekistan
[2] Acad EH Turakulov, Minist Hlth Republ Uzbekistan, Republican Specialized Sci & Pract Med Ctr Endocr, Dept Diabet Foot, Tashkent, Uzbekistan
关键词
MINERAL DENSITY;
D O I
10.9756/INTJECSE/V14I2.908
中图分类号
G76 [特殊教育];
学科分类号
040109 ;
摘要
The aim of the study was to study the role of MRI and the state of bone metabolism in the diagnosis of Charcot's foot in patients with diabetic osteoarthropathy at an early stage. Research materials and methods: 45 patients were examined (prospectively) with type 2 diabetes and Charcot's foot in the period 2021-2022 at the Academician E.H. Turakulov Endocrinology Research Center , in the department of diabetic foot. All observed patients were divided into 4 groups: 1 gy - patients with acute stage of Charcot's foot with type 2 diabetes - 25 patients, Group 2 - patients with the subacute stage of Charcot's foot - 20 patients, The control group consisted of 20 persons with DM 2 without VDS. Of the 45 patients, there were 37 men and 8 women. The average age: men was 69.12 years, women - 68, 15 years. The prescription of type 2 diabetes ranged from 17 to 25 years. The research methods included: biochemical (bilirubin, direct, indirect, lipid spectrum, ALT, AST, PTI, coagulogram, blood sugar, glycated hemoglobin, urea, creatinine, GFR, calcium, alkaline phosphatase, parathyroid hormone, vitamin D3, blood and instrumental: ECG, MRI of the feet, dopplerography of the main vessels of the legs, Ultrasound of internal organs, DEHA, fundus. The results of the study. On the MRI, we found the location of the bone marrow abnormality (edema shown in fluid-sensitive and recovery of fatty bone marrow shown in T1 sequences). The pattern tended to be periarticular. All patients had several joints and bones involved (mainly tarsometatarsal joints and metatarsal joints). In the late stages of Charcot's foot, the appearance of severe pathological changes (bone destruction, massive effusion, etc.) is characteristic on MRI. Early stage of Charcot's foot CT (computed tomography) It does not play an important role for visualization, since changes in bone marrow and soft tissues can be better visualized using MRI ( magnetic resonance imaging). CT can be used in the later stage of Charcot's foot for better visualization of bone proliferation and consolidation. Diagnosis of this disease in the early stages contributes to the timely initiation of appropriate therapy and helps to minimize the disability of these patients. In the late stages of Charcot's foot, the appearance of severe pathological changes (bone destruction, massive effusion, etc.) is characteristic on MRI Conclusions 1. Patients with diabetic foot syndrome complicated by Charcot's foot are at high risk of deficiency of 25-hydroxyvitamin D3 and calcium. 2) An early symptom on MRI with Charcot's foot was the presence of concavity of the articular surface of the talus bone against the background of sclerosis in the talus-navicular joint.
引用
收藏
页码:8079 / 8086
页数:8
相关论文
共 50 条
  • [1] Role of Dynamic MRI in the follow-up of acute Charcot foot in patients with diabetes mellitus
    Virna Zampa
    Irene Bargellini
    Loredana Rizzo
    Francesca Turini
    Simona Ortori
    Alberto Piaggesi
    Carlo Bartolozzi
    Skeletal Radiology, 2011, 40 : 991 - 999
  • [2] Role of Dynamic MRI in the follow-up of acute Charcot foot in patients with diabetes mellitus
    Zampa, Virna
    Bargellini, Irene
    Rizzo, Loredana
    Turini, Francesca
    Ortori, Simona
    Piaggesi, Alberto
    Bartolozzi, Carlo
    SKELETAL RADIOLOGY, 2011, 40 (08) : 991 - 999
  • [3] ROLE OF SERUM SCLEROSTIN ON BONE METABOLISM IN PATIENTS WITH TYPE 2 DIABETES MELLITUS
    Garcia-Martin, Antonia
    Reyes-Garcia, Rebeca
    Rozas-Moreno, Pedro
    Morales-Santana, Sonia
    Garcia-Fontana, Beatriz
    Munoz-Torres, Manuel
    OSTEOPOROSIS INTERNATIONAL, 2012, 23 : S150 - S151
  • [4] Bone mineral density in diabetes mellitus patients with and without a Charcot foot
    Christensen, Tomas M.
    Bulow, Jens
    Simonsen, Lene
    Holstein, Per E.
    Svendsen, Ole L.
    CLINICAL PHYSIOLOGY AND FUNCTIONAL IMAGING, 2010, 30 (02) : 130 - 134
  • [5] The state of bone metabolism in patients with type 2 diabetes mellitus
    Kryvenko, V., I
    Borodavko, O., I
    PATHOLOGIA, 2018, (03): : 341 - 345
  • [6] Bone metabolism in type 2 diabetes mellitus
    Isaia, GC
    Ardissone, P
    Di Stefano, M
    Ferrari, D
    Martina, V
    Porta, M
    Tagliabue, M
    Molinatti, GM
    ACTA DIABETOLOGICA, 1999, 36 (1-2) : 35 - 38
  • [7] Bone metabolism in type 2 diabetes mellitus
    G.C. Isaia
    P. Ardissone
    M. Di Stefano
    D. Ferrari
    V. Martina
    M. Porta
    M. Tagliabue
    G.M. Molinatti
    Acta Diabetologica, 1999, 36 : 35 - 38
  • [8] Charcot's joint of the wrist in type 2 diabetes mellitus
    Wrobel, M.
    Szymborska-Kajanek, A.
    Skiba, M.
    Gorska, Karasek J.
    Wittek, A.
    Grzeszczak, W.
    Strojek, K.
    EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2007, 115 (01) : 55 - 57
  • [9] Evaluation of bone metabolism and bone mass in patients with type-2 diabetes mellitus
    Oz, S. Gul
    Guven, Gulay Sain
    Kilicarslan, Alpaslan
    Calik, Nursel
    Beyazit, Yavuz
    Sozen, Tumay
    JOURNAL OF THE NATIONAL MEDICAL ASSOCIATION, 2006, 98 (10) : 1598 - 1604
  • [10] EFFECT OF TYPE 2 DIABETES MELLITUS ON BONE METABOLISM
    D'amelio, P.
    Sassi, F.
    Buondonno, I.
    Luppi, C.
    Spertino, E.
    Stratta, E.
    Di Stefano, M.
    Trento, M.
    Passera, P.
    Isaia, G. C.
    OSTEOPOROSIS INTERNATIONAL, 2015, 26 : S216 - S217